[ 68 Ga]Ga-HM or [ 68 Ga]Ga-PM: Which Is Superior for PET/CT Imaging of HMGB1-Positive Tumors?
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c01012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Kunyao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Experimental Teratology of the Ministry of Education and Center for Experimental Nuclear Medicine, School of Basic Medical Science…. Hauptthemen laut MEDLINE: HMGB1 Protein, Gallium Radioisotopes, Positron Emission Tomography Computed Tomography, Radiopharmaceuticals. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Major Science and Technology Projects of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
High mobility group box 1 (HMGB1) is highly expressed in various malignancies and has been considered as a promising molecular target for cancer diagnosis and therapy. In this study, two novel peptide-based radiotracers targeting HMGB1 were synthesized, each achieving high radiochemical purity (>95%). Of these tracers, [68Ga]Ga-HM possessed superior characteristics with a high binding affinity for the PC3 cell line (Kd = 46.11 ± 0.97 nM). Micro-PET imaging and biodistribution investigation in PC3 tumor-bearing mice revealed significant tumor uptake (SUVmax = 1.52 ± 0.10) and an excellent tumor-to-muscle ratio (6.96 ± 0.64) at 30 min post-injection. Moreover, robust imaging performance and favorable biodistribution profiles were consistently observed for [68Ga]Ga-HM across multiple distinct HMGB1-positive tumor models. These findings demonstrate that [68Ga]Ga-HM could serve as a diagnostic tracer to identify tumors with high HMGB1 expression, enabling personalized cancer treatment through the selection and monitoring of targeted therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Experimental Teratology of the Ministry of Education and Center for Experimental Nuclear Medicine, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 2…
- Department of Breast and Thyroid Surgery, The affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu 223300, China.
- Department of Nuclear Medicine, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu 223300, China.
- Department of Nuclear Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China.
ORCID-Profile: Feng Gao
Förderung
- National Major Science and Technology Projects of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, K., Zhao, W., Xu, X., Liang, T., Zhang, C., Tao, W., Li, X., & Gao, F. (2025). [ 68 Ga]Ga-HM or [ 68 Ga]Ga-PM: Which Is Superior for PET/CT Imaging of HMGB1-Positive Tumors?. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01012
Vancouver
Wang K, Zhao W, Xu X, Liang T, Zhang C, Tao W, et al. [ 68 Ga]Ga-HM or [ 68 Ga]Ga-PM: Which Is Superior for PET/CT Imaging of HMGB1-Positive Tumors?. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c01012
BibTeX
@article{Wang2025,
author = {Wang, Kunyao and Zhao, Wenqi and Xu, Xiaozhang and Liang, Ting and Zhang, Chao and Tao, Weijing and Li, Xin and Gao, Feng},
title = {[ 68 Ga]Ga-HM or [ 68 Ga]Ga-PM: Which Is Superior for PET/CT Imaging of HMGB1-Positive Tumors?},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c01012}
}
EUVIMED